KASSANDRA L GNANN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ORANGE PARK, FL NPI 1780055152
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family FL Fresenius USA Marketing, Inc. All categories
General Payments — all program years on this page
$573.69
- Category: General Payments
- Program years: PY2022–2024
- Record count: 14
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $168.77 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $168.77 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Fresenius USA Marketing, Inc. | $44.54 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $28.80 | 1 |
| BAXTER HEALTHCARE | $28.21 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $27.44 | 2 |
| Ardelyx, Inc. | $26.00 | 1 |
| Acerta Pharma LLC | $13.78 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086309335 | Bayer Healthcare Pharmaceuticals Inc. | $28.80 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105446187 | AstraZeneca Pharmaceuticals LP | $13.78 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120590912 | Baxter Healthcare | $28.21 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141516731 | CALLIDITAS THERAPEUTICS US INC. | $14.36 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141529731 | CALLIDITAS THERAPEUTICS US INC. | $13.08 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146728068 | Ardelyx, Inc. | $26.00 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154213066 | Fresenius USA Marketing, Inc. | $20.81 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154213068 | Fresenius USA Marketing, Inc. | $23.73 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.